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absolute contraindications have changed. Previous lung 
resection is no longer an absolute contraindication, and 
patients treated by lobectomy have successfully undergone 
subsequent transplantation. Each patient should be 
assessed individually. 
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Introduction 
Sarcoidosis is a multisystem granulomatous disorder of 
unknown aetiology. The respiratory system is most com- 
monly involved and therefore the majority of cases come 
under the care of respiratory physicians. Symptomatic 
cardiac involvement is found in less than 5% of patients (1); 
although cardiac granulomata have been noted in as many 
as 27% at autopsy (2). The diagnosis of cardiac sarcoidosis 
can be difficult and in established cases the prognosis is 
poor (3). Corticosteroids reportedly help and are commonly 
used, although patients are still prone to sudden death and 
progression to end-stage cardiomyopathy (4). We report a 
case of cardiac sarcoid diagnosed using magnetic resonance 
imaging (MRI) which suggests that this form of imaging 
can lead to an early diagnosis at which stage treatment may 
be more likely to be beneficial. 
Received 25 February 1997 and accepted in revised form 2 June 
1997. 
Case Report 
A 55-year-old factory foreman initially presented following 
an episode of syncope and two episodes of near syncope. 
These episodes were all of short duration, occurred over a 
period of 6 months and were not associated with palpita- 
tions or chest pain. Clinical examination was completely 
normal, blood pressure was 130/80, breath sounds were 
vesicular and heart sounds were normal. He was an 
ex-smoker who had been previously well but did describe 
the occurrence of red blotches on his lower legs 18 months 
earlier, which had been self-limiting. 
Electrocardiography showed sinus rhythm with a QRS 
axis of+45 degrees. Twenty-four hour Holter monitoring 
showed sinus rhythm with an occasional dropped beat. His 
chest X-ray revealed bilateral hilar lymphadenopathy, 
raising the possibility of sarcoidosis. Spirometry was supra- 
normal. HRCT of the thorax revealed huge paratracheal, 
subcarinal and parabronchial lymphadenopathy but no 
evidence of interstitial lung involvement. Fibre-optic bron- 
choscopy revealed a small nodule in the apical segment of 
the right lower lobe, biopsy of which showed noncaseating 
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PLATE 1. MRI pre-corticosteroids. T, weighted cardiac 
gated fast spin echo axial image (TR3692 TElOO) demon- 
strating high signal in the endocardium and myocardium 
of the left ventricle (straight arrow), and significant medi- 
astinal lymphadenopathy (curved arrow). The high signal 
in the endocardium suggests infiltration, and, in the pres- 
ence of appropriate lymphadenopathy, this is most prob- 
ably due to sarcoidosis. The high signal crossing the left 
ventricle from posterior to anterior is phase artefact from 
the aorta. 
epitheloid granulomas consistent with a diagnosis of sar- 
coidosis. Serum angiotensin enzyme (ACE) level was raised 
at90iull’ (normal range 8-52 iu I- ‘). 
The history of episodes of near syncope raised suspicions 
of cardiac involvement with sarcoid. He therefore under- 
went extensive cardiological investigation. Two further 24-h 
tapes, a treadmill exercise test, transthoracic and trans- 
oesophageal echocardiograms were all within normal 
limits. In particular, there was no evidence of arrhythmia or 
cardiac involvement with sarcoid. He further underwent 
cardiac magnetic resonance imaging (MRI). T, (pre and 
post-gadolinium) and T, (weighted axial fast spin echo 
sequences) images were performed using R wave cardiac 
gating on a 0.5 Tesla Vecta GE. On the T, weighted 
sequence there was a marked increase in signal in the 
inter-ventricular septum, the left ventricular myocardium 
and the endocardial cushion (Plate 1). These features are 
diagnostic of cardiac infiltration and, in the presence of 
hilar lymphadenopathy, suggest cardiac sarcoid. These 
features were also present on the post-gadolinium T, 
weighted images but were more subtle. The patient was 
therefore started on 40 mg prednisolone per day, reducing 
to 10 mg over a period of 3 months. During this time he 
had no further syncopal attacks and his serum ACE 
decreased to 12 iu 1 - ‘. Cardiac MRI was repeated after 
2 months on prednisolone. This showed almost complete 
absence of high signal on T, weighted sequences and 
only faint high signal could be seen in the left ventricle, 
even when T, weighting was increased (Plate 2). There 
was also a significant reduction in the size of the 
lymphadenopathy. 
PLATE 2. MRI scan 2 months post-corticosteroids. 
Despite increasing the T, weighting on this axial image 
(TR4515 TElOO), only slight increased signal can be seen 
in the endomyocardium (straight arrow). The mediastinal 
lymphadenopathy is also much reduced in size (curved 
arrow). Increased respiratory artefact degrades the image 
slightly but this was related to the patient’s respiratory 
pattern rather than to technical factors. 
Discussion 
Most patients with sarcoidosis come under the care of 
respiratory physicians, who might consider stage I pulmon- 
ary sarcoid a relatively benign disease, with 80% of cases 
resolving spontaneously within a year of diagnosis (5). This 
case shows that cardiac involvement can occur in patients 
with early pulmonary disease. Although the natural history 
of cardiac sarcoid is unknown, its presence may denote a 
poor prognosis with a high reported incidence of sudden 
death (6). In subjects with established cardiac disease 
corticosteroids are recommended and are reported to 
decrease arrhythmias and symptoms, although there are no 
controlled trials of such therapy. Sudden death and pro- 
gressive cardiac failure can still occur in patients on treat- 
ment with corticosteroids (4), and there is concern that 
corticosteroids might exacerbate myocardial thinning and 
give rise to ventricular aneurysms (6). Permanent pace- 
makers and implantable defibrillators have been used in 
subjects shown to be susceptible to arrhythmias by electro- 
physiological studies but do not protect these patients from 
progression to end-stage congestive cardiac failure. Trans- 
plantation has been used, although sarcoid can recur in the 
transplanted organ (7). The treatment of cardiac sarcoid is 
therefore difficult. 
Early intervention with corticosteroids prior to estab- 
lished cardiac damage might theoretically improve prog- 
nosis. To this end any investigation which will detect 
cardiac sarcoid at any early stage might be useful. Endo- 
cardial biopsy has limited value due to the patchy distribu- 
tion of the granuloma (8). Thallium-201 myocardial 
scintigraphy can be useful in suggesting the diagnosis, 
especially if coronary heart disease can be excluded (9). The 
potential of MRI in the diagnosis of cardiac sarcoid was 
mentioned briefly in a recent editorial (9), although its place 
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in clinical management remains to be fully determined. 
MRI in cardiac sarcoid classically reveals high signal 
lesions which are patchy, discrete and have a predilection 
for the left ventricle and the septum (10). Although cardiac 
amyloidosis could give a similar appearance the diagnosis 
in this case is confirmed by the associated histologically 
proven bronchial sarcoid. MRI can be used to guide 
subsequent endocardial biopsies (1O;ll). This case demon- 
strates the value of MRI in diagnosing cardiac sarcoidosis 
when other cardiac investigations were negative, and shows 
that early treatment with corticosteroids can result in 
almost complete resolution of the MRI changes. A similar 
case has been reported previously in the French literature 
(12) although, in our case: cardiac resolution was matched 
by suppression of the serum ACE levels, a marker of 
disease activity. 
This is much to be learned about the incidence and 
natural history of cardiac sarcoidosis. Prognosis in 
asymptomatic patients is unclear and the value of early 
intervention uncertain. MRI is a valuable non-invasive 
investigation which should enable detection of subclinical 
and clinical cardiac sarcoid. We would suggest that MRI 
should be used more widely in the investigation of patients 
with sarcoid, even if the pulmonary disease is mild and 
cardiac symptoms vague. Cardiac sarcoid can be associated 
with a poor prognosis, and MRI may enable earlier identi- 
fication of patients who require careful review. It should 
also allow early intervention with corticosteroids, which, 
in this case, would seem to have reversed the cardiac 
abnormalities. 
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